2B71 Stock Overview
iShares V Public Limited Company - iShares S&P 500 GBP Hedged UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares V Public Limited Company - iShares S&P 500 GBP Hedged UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£130.36 |
52 Week High | UK£137.50 |
52 Week Low | UK£102.92 |
Beta | 0 |
1 Month Change | -4.57% |
3 Month Change | 2.89% |
1 Year Change | 24.87% |
3 Year Change | 20.06% |
5 Year Change | 65.98% |
Change since IPO | 97.52% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
2B71 | DE Capital Markets | DE Market | |
---|---|---|---|
7D | -3.2% | -0.8% | -2.0% |
1Y | 24.9% | 17.8% | -0.3% |
Return vs Industry: 2B71 exceeded the German Capital Markets industry which returned 17.8% over the past year.
Return vs Market: 2B71 exceeded the German Market which returned -0.3% over the past year.
Price Volatility
2B71 volatility | |
---|---|
2B71 Average Weekly Movement | 2.5% |
Capital Markets Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2B71 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2B71's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | n/a | www.ishares.com/uk/individual/en/products/251904/IGUS |
iShares V Public Limited Company - iShares S&P 500 GBP Hedged UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States.
iShares V Public Limited Company - iShares S&P 500 GBP Hedged UCITS ETF Fundamentals Summary
2B71 fundamental statistics | |
---|---|
Market cap | €776.70m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 2B71 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2B71 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 2B71 perform over the long term?
See historical performance and comparison